Hearing loss in pediatric cancer survivors treated with cisplatin.
Child Development and Rehabilitation Center, Department of Pediatrics, Oregon Health and Science University, Portland, Oregon, USA.
Kristin
K
Knight
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002528:Cerebellar Neoplasms / Q000188:drug therapy; D002945:Cisplatin / Q000009:adverse effects*; D034381:Hearing Loss / Q000139:chemically induced* / Q000451:nursing* / Q000628:therapy; D006801:Humans; D008527:Medulloblastoma / Q000188:drug therapy; D017741:Survivors
D000970:Antineoplastic Agents; D002945:Cisplatin